- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Dysregulated Gab1 signalling in triple negative breast cancer ; volume:22 ; number:1 ; day:6 ; month:3 ; year:2024 ; pages:1-19 ; date:12.2024
Cell communication and signaling ; 22, Heft 1 (6.3.2024), 1-19, 12.2024
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12964-024-01542-9
- URN
-
urn:nbn:de:101:1-2405100917146.650026400805
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bongartz, Hannes
- Mehwald, Nora
- Seiß, Elena A.
- Schumertl, Tim
- Naß, Norbert
- Dittrich, Anna
- SpringerLink (Online service)
Ähnliche Objekte (12)
Metastatic Triple-Negative Breast Cancer
WNT10B/β‐catenin signalling induces HMGA2 and proliferation in metastatic triple‐negative breast cancer
Naphthoquinone-derived ZSW-4B induces apoptosis in triple-negative breast cancer via AMPK signalling activation
Comprehensive analysis of the metabolomics and transcriptomics uncovers the dysregulated network and potential biomarkers of Triple Negative Breast Cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Simultaneous inhibition of FAK and ROS1 synergistically repressed triple-negative breast cancer by upregulating p53 signalling
Overcoming acquired resistance to HSP90 inhibition by targeting JAK-STAT signalling in triple-negative breast cancer
Metabolic characterization of triple negative breast cancer
Triple negative breast cancer: Pitfalls and progress
Immunotherapeutic interventions of Triple Negative Breast Cancer
Triple negative breast cancer: A continuing challenge
Metastatic Triple-Negative Breast Cancer
WNT10B/β‐catenin signalling induces HMGA2 and proliferation in metastatic triple‐negative breast cancer
Naphthoquinone-derived ZSW-4B induces apoptosis in triple-negative breast cancer via AMPK signalling activation
Comprehensive analysis of the metabolomics and transcriptomics uncovers the dysregulated network and potential biomarkers of Triple Negative Breast Cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Simultaneous inhibition of FAK and ROS1 synergistically repressed triple-negative breast cancer by upregulating p53 signalling
Overcoming acquired resistance to HSP90 inhibition by targeting JAK-STAT signalling in triple-negative breast cancer
Metabolic characterization of triple negative breast cancer
Triple negative breast cancer: Pitfalls and progress
Immunotherapeutic interventions of Triple Negative Breast Cancer
Triple negative breast cancer: A continuing challenge
Metastatic Triple-Negative Breast Cancer
WNT10B/β‐catenin signalling induces HMGA2 and proliferation in metastatic triple‐negative breast cancer
Naphthoquinone-derived ZSW-4B induces apoptosis in triple-negative breast cancer via AMPK signalling activation
Comprehensive analysis of the metabolomics and transcriptomics uncovers the dysregulated network and potential biomarkers of Triple Negative Breast Cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Simultaneous inhibition of FAK and ROS1 synergistically repressed triple-negative breast cancer by upregulating p53 signalling
Overcoming acquired resistance to HSP90 inhibition by targeting JAK-STAT signalling in triple-negative breast cancer
Metabolic characterization of triple negative breast cancer
Triple negative breast cancer: Pitfalls and progress
Immunotherapeutic interventions of Triple Negative Breast Cancer